TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
VCEL

Vericel Corp Ord

Healthcare · Biotechnology

39.70$ +1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Vericel Corp Ord (VCEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 488 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VCEL
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
18 21 12 9.5 13 12 12 12 18 34 45 33 26 19 33 7.7 15 9.2 48 34 49 55 119 153 206 244 273 354 433 488
17 20 12 9.0 13 12 11 12 18 33 44 30 24 18 32 6.2 14 8.5 41 27 45 51 113 112 124 158 187 206 213 247
1.9 1.3 2.1 7.5 2.1 11 8.6 11 17 14 9.0 13 16 17 31 5.5 14 8.1 30 15 23 27 18 27 34 68 51 69 75 100
1.9 20 11 7.5 13 11 9.6 11 17 32 43 28 22 17 31 5.5 14 8.1 30 15 23 27 83 70 76 103 120 110 116 137
0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 8.2 11 17 18 23 32 35 37 47 58 61 85
– – 1.1 1.1 0.7 0.7 1.4 0.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.4 3.5 3.8 3.6 6.8 9.4 13 16 13 17 18
– – – 0.3 0.2 0.2 0.3 0.3 0.8 1.2 2.7 2.2 1.5 1.0 – 1.6 1.2 0.7 2.9 4.0 3.9 4.1 5.9 32 58 59 57 – – –
– – – – – – – – – – – – – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – –
– – – – – – – – – – – – – – – 0.0 0.0 0.0 3.2 2.9 0.0 0.0 – – – – 7.5 6.9 6.3 5.6
1.8 2.1 1.5 1.0 1.0 1.0 0.8 0.6 0.6 0.9 2.5 4.6 2.9 2.0 30 21 5.7 5.3 12 12 24 32 16 42 71 73 81 128 141 133
1.8 2.1 1.5 1.0 1.0 1.0 0.8 0.6 0.6 0.9 2.5 3.5 2.1 1.7 30 21 5.7 5.3 12 12 13 13 15 20 22 26 37 46 50 49
0.1 0.1 0.1 – – – – – – – 0.4 0.4 0.5 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.8 0.4 – 5.5 4.4 3.0 4.3 6.2 9.3 14
1.5 1.9 0.8 0.8 0.9 0.6 0.4 0.2 0.2 0.4 0.5 0.3 0.9 1.0 0.0 2.2 2.8 2.4 5.8 7.6 6.5 5.6 7.1 6.3 6.8 9.0 17 22 24 16
– – – – – – – – – – 1.1 0.8 0.3 0.1 – 0.0 0.0 0.0 0.1 0.1 0.0 17 – – – – – – – –
17 19 11 8.5 12 11 11 12 18 33 42 28 23 17 2.9 -13 9.5 3.9 36 22 25 23 102 111 134 170 192 226 292 355
-41 -49 -59 -70 -80 -86 -94 -103 -114 -126 -142 -160 -180 -196 -222 -242 -275 -288 -308 -324 -344 -361 -369 -379 -376 -383 -400 -403 -393 -376
0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.3 0.5 0.6 0.7 0.7 0.8 0.9 1.2 1.9 2.1 3.0 12 24 23 33 40 44 47 46 47 48 52 52

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?